Back

The use of wearable cardioverter defibrillator among patients suffering from myocarditis: data from a multicenter registry

27 August 2023 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Risk stratification in ventricular arrhythmias Wearables and m-Health ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Ibrahim El-Battrawy

Ruhr University Bochum, Bochum (Germany)

4 More presentations in this session

Presentation thumbnail
Predicting ventricular arrhythmia inducibility in ajmaline-induced brugada type I pattern: validation of the dST-Tiso interval
Doctor S. Iacopino (Cotignola, IT)
Abstract Slides
Presentation thumbnail
Implantable loop recorder monitoring in inherited cardiomyopathies: yield of clinically relevant arrhythmias
Doctor A. Trancuccio (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Asymptomatic Brugada patients: long-term prognosis from a large prospective study.
Associate Professor C. Giustetto (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death
Professor A. Auricchio (Lugano, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in ventricular arrhythmias
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 12:00 CET
You may be interested in
thumbnail
Congress Session
Risk stratification in ventricular arrhythmias
thumbnail
Congress Presentation
Sudden cardiac arrest in patients with newly diagnosed NICM or MI/CAD - nationwide analysis of >19.000 patients with a WCD
thumbnail
Congress Session
'Shocking' news on implantable cardioverter defibrillators

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources